ArticleActa pharmaceutica Sinica. B2023

Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects.

Wei Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.